| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/25/2008 | US20080317888 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis |
| 12/25/2008 | US20080317875 Inhibitor of PI3 kinase-dependent inflammatory cytokine synthesis and method for inhibiting the same |
| 12/25/2008 | US20080317874 Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| 12/25/2008 | US20080317858 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3--2-thiophenecarboxamide |
| 12/25/2008 | US20080317847 Hydrostatic delivery system for controlled delivery of agent |
| 12/25/2008 | US20080317834 Compounds and methods for modulating cerebral amyloid angiopathy |
| 12/25/2008 | US20080317813 Nanobead releasing medical devices |
| 12/25/2008 | US20080317809 Use of K -252a and Kinase Inhibitors for the Prevention or Treatment of Hmgb1-Associated Pathologies |
| 12/25/2008 | US20080317767 Tripartitle Raftophilic Strutures and their Use |
| 12/25/2008 | US20080317761 Peptide-Mediated Protein Transduction Into Cells of the Hematopoietic Lineage |
| 12/25/2008 | US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/25/2008 | US20080317746 Anti-Il2 Antibodies |
| 12/25/2008 | US20080317720 Fat-Derived Progenitor Cell and Use Thereof |
| 12/24/2008 | WO2008157563A2 Deuterium-enriched clopidogrel |
| 12/24/2008 | WO2008157393A1 Compositions comprising sulfide alone or in combination with nitric oxide and their use to |
| 12/24/2008 | WO2008157240A1 Substituted piperazines |
| 12/24/2008 | WO2008157191A2 Quinazoline derivatives as pi3 kinase inhibitors |
| 12/24/2008 | WO2008156831A2 Renin inhibitors |
| 12/24/2008 | WO2008156817A2 Renin inhibitors |
| 12/24/2008 | WO2008156699A1 Targeted oxygen delivery via intravenous or intra-arterial infusion of oxygenated polymerized hemoglobin solutions |
| 12/24/2008 | WO2008156685A2 Tendon stem cells |
| 12/24/2008 | WO2008156645A2 Pharmaceutical compositions and uses |
| 12/24/2008 | WO2008156550A2 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine |
| 12/24/2008 | WO2008156208A1 5-phenyl-3-pyridazinone derivative |
| 12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 12/24/2008 | WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1 |
| 12/24/2008 | WO2008155335A1 Protease activated receptor-1 antagonists for the treatment of atrial fibrillation |
| 12/24/2008 | WO2008155017A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases |
| 12/24/2008 | WO2008155016A1 Substituted furopyrimidines and use thereof |
| 12/24/2008 | WO2008154812A1 A new use of traditional chinese medical composition |
| 12/24/2008 | WO2008154738A1 Azapeptides as cd36 binding compounds |
| 12/24/2008 | WO2008154705A1 Transdermal delivery of active agents |
| 12/24/2008 | WO2008136037A3 Chemical-catalytic method for the peracylation of oleuropein and its products of hydrolysis |
| 12/24/2008 | WO2008124173A8 Combination therapy for cardiac revascularization and cardiac repair |
| 12/24/2008 | WO2008060476A3 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 12/24/2008 | WO2008060372A3 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 12/24/2008 | WO2008051291A3 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 12/24/2008 | WO2008048866A3 Bicyclic heteroaromatic compounds |
| 12/24/2008 | EP2006301A1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 12/24/2008 | EP2005949A1 Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent |
| 12/24/2008 | EP2004669A1 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 12/24/2008 | EP2004668A2 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 12/24/2008 | EP2004658A1 Condensed imidazole derivatives as aromatase inhibitors |
| 12/24/2008 | EP2004657A1 Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 12/24/2008 | EP2004656A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions |
| 12/24/2008 | EP2004627A2 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 12/24/2008 | EP2004619A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases |
| 12/24/2008 | EP2004603A2 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use |
| 12/24/2008 | EP2004576A1 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use |
| 12/24/2008 | EP2004186A2 Varenicline standards and impurity controls |
| 12/24/2008 | EP2004173A2 Use of aminapthone for the preparation of a medicament for treating arteriophaties |
| 12/24/2008 | EP2004167A1 Renin inhibitors for the treatment of hypertension |
| 12/24/2008 | EP2004139A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment |
| 12/24/2008 | EP1627866B1 Carboxylic acid compound and medicine containing the same |
| 12/24/2008 | EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 12/24/2008 | EP1501503B1 Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatment of central nervous system disturbances |
| 12/24/2008 | EP1147115B3 Tricyclic benzodiazepines as vasopressin receptor antagonists |
| 12/24/2008 | DE69922977C5 Neue Kristallmodifikation von Torasemid New crystal modification of torasemide |
| 12/24/2008 | DE102007028407A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028406A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028320A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028319A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | CN101330930A Therapeutic agent for heart disease |
| 12/24/2008 | CN101330919A Pharmaceutical composition including (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrim idin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid |
| 12/24/2008 | CN101328478A Protein having antiplatelet embolism activity, production method and use thereof |
| 12/24/2008 | CN101328221A Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
| 12/24/2008 | CN101328167A Preparation of losartan |
| 12/24/2008 | CN101328166A 2-dihydroindole ketone derivate as protein kinase inhibitor and histone deacetylase inhibitor |
| 12/24/2008 | CN101328152A Piperazidine compound and pyridine compound |
| 12/24/2008 | CN101327286A Pain-relieving anti-inflammation medicament and preparation method thereof and use |
| 12/24/2008 | CN101327281A Chinese medicine for treating palsy facial paralysis |
| 12/24/2008 | CN101327276A Use of ball containing moschus, bear gall and antelope horn in preparing medicament for treating coronary heart disease |
| 12/24/2008 | CN101327254A Composition for treating hypertensive |
| 12/24/2008 | CN101327253A Chewing gum for reducing blood pressure |
| 12/24/2008 | CN101327246A Radix astragali medicinal materials, intermediate body and method for testing fingerprint of formulation thereof as well as standard fingerprint |
| 12/24/2008 | CN101327244A Decolored and debitterized Momordica grosvenori extract and preparation method thereof |
| 12/24/2008 | CN101327232A Method for preparing Hippophae rhamnoides flavones separated and purified by polyamide and uses thereof |
| 12/24/2008 | CN101327229A Oral Chinese medicine for treating hemorrhoid |
| 12/24/2008 | CN101327228A Low-acid gingko flavones and extracting method thereof |
| 12/24/2008 | CN101327221A Medical use of Ophiopogon root saponin D as tissue factor pathway inhibitor |
| 12/24/2008 | CN101327215A Medicament composition containing protoberberine type alkaloids |
| 12/24/2008 | CN101327214A Medicine use of isoquinoline alkaloids as tissue factor inhibitor |
| 12/24/2008 | CN101327213A Irbesartan and hydrochlorothiazide pharmaceutical composition and preparation method thereof |
| 12/24/2008 | CN101327207A Medicament composition and use thereof for treating coronary heart disease |
| 12/24/2008 | CN101327199A Carotenoids as anti-hypertension agents |
| 12/24/2008 | CN101327195A Losartan potassium and hydrochlorothiazide tablets and preparation method thereof |
| 12/24/2008 | CN101327194A Hydrochloric acid diltiazem freeze-dried powder injection for injections and preparation method thereof |
| 12/24/2008 | CN101327177A Red sage root toothpaste |
| 12/24/2008 | CN101326954A Method for producing feed containing Ganoderma lucidum acid from wheat straw transformed by Ganoderma lucidum |
| 12/24/2008 | CN101326953A Anti-hypertensive casein active peptide and method for producing the same as well as use thereof |
| 12/24/2008 | CN100445390C High activity, low antigen glucokinase derivant and preparation method |
| 12/24/2008 | CN100445389C Low antigen recombination glucokinase mutant and its preparation method |
| 12/24/2008 | CN100445295C 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 12/24/2008 | CN100445288C Bilobalide B derivatives and pharmaceutical application thereof |
| 12/24/2008 | CN100445266C MCH antagonists and their use in treatment of obesity |
| 12/24/2008 | CN100445265C Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same |
| 12/24/2008 | CN100444874C Medicinal composition for treating apoplexia and its preparation method |
| 12/24/2008 | CN100444867C Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as estrofen-like organ-selective medicament without uteroetropic effects |